IN2012DN02463A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02463A
IN2012DN02463A IN2463DEN2012A IN2012DN02463A IN 2012DN02463 A IN2012DN02463 A IN 2012DN02463A IN 2463DEN2012 A IN2463DEN2012 A IN 2463DEN2012A IN 2012DN02463 A IN2012DN02463 A IN 2012DN02463A
Authority
IN
India
Prior art keywords
present
weight management
relates
field
bifidobacterium longum
Prior art date
Application number
Other languages
English (en)
Inventor
De Bercik Elena Verdu
Premysl Bercik
Stephen Michael Collins
Degonda Gabriela Bergonzelli
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41683555&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN02463(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN02463A publication Critical patent/IN2012DN02463A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN2463DEN2012 2009-09-30 2010-09-28 IN2012DN02463A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09171866A EP2308499A1 (fr) 2009-09-30 2009-09-30 Bifidobacterium longum ATCC BAA-999 (BL999) et contrôle du poids
PCT/EP2010/064348 WO2011039176A1 (fr) 2009-09-30 2010-09-28 Bifidobacterium longum atcc baa-999 (bl999) et contrôle du poids

Publications (1)

Publication Number Publication Date
IN2012DN02463A true IN2012DN02463A (fr) 2015-05-22

Family

ID=41683555

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2463DEN2012 IN2012DN02463A (fr) 2009-09-30 2010-09-28

Country Status (15)

Country Link
US (1) US20120244125A1 (fr)
EP (2) EP2308499A1 (fr)
JP (1) JP5911424B2 (fr)
CN (1) CN102665737A (fr)
AR (1) AR078485A1 (fr)
AU (1) AU2010303020B2 (fr)
BR (1) BR112012007109A2 (fr)
CA (1) CA2775976A1 (fr)
CL (1) CL2012000809A1 (fr)
IN (1) IN2012DN02463A (fr)
MX (1) MX2012003612A (fr)
PH (1) PH12012500569A1 (fr)
RU (1) RU2567660C2 (fr)
SG (1) SG10201406169VA (fr)
WO (1) WO2011039176A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5615285B2 (ja) * 2010-03-18 2014-10-29 森永乳業株式会社 貧血の予防又は治療用組成物
EP2452575A1 (fr) * 2010-11-15 2012-05-16 Nestec S.A. Analyse de formule nutritionnelle personnalisée en fonction de l'âge avec des probiotiques
FI20116008A0 (fi) 2011-10-12 2011-10-12 Maeyrae Maekinen Annika Viskeraalisen rasvan estäminen ja diagnostisointi
EP4509182A3 (fr) 2012-11-19 2025-05-21 Université Catholique de Louvain Use of akkermansia for treating metabolic disorders
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
NZ711956A (en) 2013-03-08 2018-06-29 Axiom Foods Inc Rice protein supplements
JP6234331B2 (ja) * 2014-06-13 2017-11-22 森永乳業株式会社 統合失調症治療剤
TWI572713B (zh) * 2014-10-31 2017-03-01 豐華生物科技股份有限公司 抗肥胖之乳酸菌菌株及其於食品組成物以及醫藥組成物之應用
JP6650728B2 (ja) * 2015-03-06 2020-02-19 株式会社ファンケル ダイエット用の製剤
JP6843140B2 (ja) * 2015-12-11 2021-03-17 プリシジョンバイオティクス・グループ・リミテッド 肥満および関連する代謝障害を処置するためのビフィドバクテリウム・ロングム
JP6847577B2 (ja) * 2015-12-28 2021-03-24 森永乳業株式会社 ビフィドバクテリウム属細菌および／または乳酸菌の増殖促進および／または減少抑制剤
RU2757213C2 (ru) * 2016-04-14 2021-10-12 ДюПон НЬЮТРИШН БАЙОСАЙЕНСИЗ АпС Бифидобактерии для увеличения безжировой массы тела
IT201600105831A1 (it) * 2016-10-20 2018-04-20 Probiotical Spa Una composizione a base di un estratto di Irvingia gabonensis e ceppi di Bifidobatteri per la regolazione e riduzione del peso corporeo
KR101920219B1 (ko) * 2017-03-08 2018-11-20 서울대학교산학협력단 비피더스균을 포함하는 비만 예방 또는 개선용 조성물
EP3634155A4 (fr) 2017-05-12 2021-02-17 Axiom Foods Inc. Produits de riz et systèmes et procédés de fabrication de ceux-ci
EP3673044A1 (fr) 2017-08-25 2020-07-01 University College Cork-National University of Ireland, Cork Utilisation debifidobacterium longum pour traiter l'obésité et permettre le contrôle du poids
AU2017438436B2 (en) * 2017-10-31 2022-01-13 Morinaga Milk Industry Co., Ltd. Muscle-building composition
US20200345051A1 (en) 2017-11-24 2020-11-05 University College Cork, National University Of Ireland, Cork A composition comprising a cohort of bacteria
CN112672749B (zh) * 2018-04-11 2024-07-23 韩国生命工学研究院 具有肥胖预防或治疗效果的新的长双歧杆菌菌株或鼠李糖乳杆菌菌株及其用途
CN111187734A (zh) * 2019-12-25 2020-05-22 生合生物科技（扬州）有限公司 长双歧杆菌bl986、由其制备的冻干粉及冻干粉的应用
JP7475155B2 (ja) * 2020-02-14 2024-04-26 森永乳業株式会社 持久力向上用組成物
CN115666275A (zh) * 2020-05-20 2023-01-31 雀巢产品有限公司 禾本科和/或豆科纤维对长双歧杆菌的存活能力和代谢活性的有益效果
EP4070670A1 (fr) 2021-04-08 2022-10-12 University College Cork-National University of Ireland Cork Lacticaseibacillus paracasei em025-11 et ses utilisations
WO2026017760A1 (fr) 2024-07-16 2026-01-22 University College Cork - National University Of Ireland, Cork Compositions bactériennes et leurs utilisations pour le traitement ou la prévention d'une maladie immunitaire

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61109729A (ja) * 1984-11-05 1986-05-28 Advance Res & Dev Co Ltd コレステロ−ル低下剤
JP2687229B2 (ja) * 1988-11-11 1997-12-08 株式会社ヤクルト本社 血圧降下剤
JP4280016B2 (ja) * 2002-02-28 2009-06-17 雪印乳業株式会社 糖尿病合併症予防・改善・治療剤
JP2003252771A (ja) * 2002-03-04 2003-09-10 Snow Brand Milk Prod Co Ltd 加齢に伴う代謝異常疾患の予防・改善・治療剤
SE529185C2 (sv) * 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
JP2007169200A (ja) * 2005-12-21 2007-07-05 Morinaga Milk Ind Co Ltd インフルエンザ感染予防のための医薬及び飲食品
DK1981516T3 (en) * 2006-01-27 2018-12-03 Dupont Nutrition Biosci Aps APPLICATION OF PROBIOTIC MICROORGANISMS FOR TREATMENT AND PREVENTION OF OBESIS AND RELATED DISORDERS
CA2642431A1 (fr) * 2006-02-15 2007-08-23 Nestec S.A. Utilisation de bifidobacterium longum pour la prevention et le traitement d'inflammations
US20090170772A1 (en) * 2006-03-31 2009-07-02 Morinaga Milk Industry Co., Ltd. Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator
KR20080075971A (ko) * 2007-02-14 2008-08-20 (주)네오팜 프로바이오틱스 복합 제제
EP1974734A1 (fr) 2007-03-28 2008-10-01 Nestec S.A. Probiotiques pour la réduction du risque d'obésité
EP2022502A1 (fr) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus et contrôle de poids
UA30077U (uk) * 2007-10-18 2008-02-11 Одесская Национальная Академия Пищевых Технологий Композиція для йогурту діабетичного призначення
UA31009U (uk) * 2007-10-18 2008-03-25 Одесская Национальная Академия Пищевых Технологий Кисломолочний напій діабетичного призначення
JP2009143820A (ja) * 2007-12-12 2009-07-02 Tsujido Chemical Corp 高尿酸血症の予防または改善剤

Also Published As

Publication number Publication date
CL2012000809A1 (es) 2012-07-13
RU2012117804A (ru) 2013-11-20
AR078485A1 (es) 2011-11-09
PH12012500569A1 (en) 2012-10-22
AU2010303020A1 (en) 2012-04-19
CN102665737A (zh) 2012-09-12
CA2775976A1 (fr) 2011-04-07
AU2010303020B2 (en) 2014-11-20
WO2011039176A1 (fr) 2011-04-07
JP2013506631A (ja) 2013-02-28
SG10201406169VA (en) 2014-11-27
RU2567660C2 (ru) 2015-11-10
EP2308499A1 (fr) 2011-04-13
EP2482829A1 (fr) 2012-08-08
US20120244125A1 (en) 2012-09-27
MX2012003612A (es) 2012-04-19
JP5911424B2 (ja) 2016-04-27
BR112012007109A2 (pt) 2016-07-05

Similar Documents

Publication Publication Date Title
IN2012DN02463A (fr)
PH12012501257A1 (en) Capsule for the preparation of a beverage comprising an identification code
TN2011000673A1 (en) Bace inhibitors
MX2011008398A (es) Lactobacillus helveticus cncm i-4095 y el control del peso.
MX350234B (es) Compuestos de enlace especificos de bacterias gram-positivas.
IN2012DN01638A (fr)
PH12012501355A1 (en) Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
MX355543B (es) Macrociclos peptidomiméticos.
MX339878B (es) Nuevas formas solidas de clorhidrato de bendamustina.
MX2011007930A (es) Conjugados de insulina cristalina.
MY158992A (en) Forms of rifaximin and uses thereof
PH12012501550A1 (en) Modified tuberculosis antigens
MX2013001473A (es) Anticuerpos contra il-18r1 y usos de los mismos.
MX345063B (es) Cepas probióticas para mejorar el sistema nervioso entérico.
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
MX336323B (es) Anticuerpos de anti-poliubiquitina y metodos de uso.
MX2011008400A (es) Lactobacillus rhamnosus cncm i-4096 y el control del peso.
MX2012007898A (es) Metodos para proveer terapia de perdida de peso en pacientes con depresion mayor.
PH12014501061B1 (en) Tricyclic compounds, compositions comprising them and uses thereof
MX2012013835A (es) Cepas probioticas para aumentar la resistencia transepitelial.
MY158310A (en) Prevention and treatment of allergic diarrhoea
IN2012DN03404A (fr)
MX2015005897A (es) Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal.
PH12012501547A1 (en) Methods of preparing thiazolidines
UA102047C2 (uk) ГЕПАТОЗАХИСНА ТА АНТИОКСИДАНТНА АКТИВНІСТЬ ШТАМУ РЕЛІКТОВИХ БАКТЕРІЙ BACILLUS sp. F